These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 31483624)

  • 1. Fast and Noninvasive Diagnosis of Cervical Cancer by Coherent Anti-Stokes Raman Scattering.
    Aljakouch K; Hilal Z; Daho I; Schuler M; Krauß SD; Yosef HK; Dierks J; Mosig A; Gerwert K; El-Mashtoly SF
    Anal Chem; 2019 Nov; 91(21):13900-13906. PubMed ID: 31483624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman spectroscopy for screening and diagnosis of cervical cancer.
    Lyng FM; Traynor D; Ramos IR; Bonnier F; Byrne HJ
    Anal Bioanal Chem; 2015 Nov; 407(27):8279-89. PubMed ID: 26277185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman microspectroscopy for the early detection of pre-malignant changes in cervical tissue.
    Rashid N; Nawaz H; Poon KW; Bonnier F; Bakhiet S; Martin C; O'Leary JJ; Byrne HJ; Lyng FM
    Exp Mol Pathol; 2014 Dec; 97(3):554-64. PubMed ID: 25445502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI imaging as a specific diagnostic tool for routine cervical cytology specimens.
    Schwamborn K; Krieg RC; Uhlig S; Ikenberg H; Wellmann A
    Int J Mol Med; 2011 Mar; 27(3):417-21. PubMed ID: 21174066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic spectro-cytology revealing differential recognition of cervical cancer lesions by label-free surface enhanced Raman fingerprints and chemometrics.
    Karunakaran V; Saritha VN; Joseph MM; Nair JB; Saranya G; Raghu KG; Sujathan K; Kumar KS; Maiti KK
    Nanomedicine; 2020 Oct; 29():102276. PubMed ID: 32736038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous hyperspectral differential-CARS, TPF and SHG microscopy with a single 5 fs Ti:Sa laser.
    Pope I; Langbein W; Watson P; Borri P
    Opt Express; 2013 Mar; 21(6):7096-106. PubMed ID: 23546091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-HE images derived from CARS/TPEF/SHG multimodal imaging in combination with Raman-spectroscopy as a pathological screening tool.
    Bocklitz TW; Salah FS; Vogler N; Heuke S; Chernavskaia O; Schmidt C; Waldner MJ; Greten FR; Bräuer R; Schmitt M; Stallmach A; Petersen I; Popp J
    BMC Cancer; 2016 Jul; 16():534. PubMed ID: 27460472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
    Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
    Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding multimodal microscopy by high spectral resolution coherent anti-Stokes Raman scattering imaging for clinical disease diagnostics.
    Meyer T; Chemnitz M; Baumgartl M; Gottschall T; Pascher T; Matthäus C; Romeike BF; Brehm BR; Limpert J; Tünnermann A; Schmitt M; Dietzek B; Popp J
    Anal Chem; 2013 Jul; 85(14):6703-15. PubMed ID: 23781826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Tsiambas E; Riziotis C
    Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
    Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.